Celldex Therapeutics | CLDX - Credores Comerciais

Preço das Ações
30.99
Mudança Diária
-0.81 -2.55%
Mensal
0.55%
Anual
53.80%
Q1 Previsão
29.97




Credores Comerciais Alterar Data
AbbVie USD 3.59B 28.65B 2025-12
Agenus USD 82.99M 2.3M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Celldex Therapeutics USD 1.18M 3.09M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Northwest Biotherapeutics 27.22M 5.8M 2025-03
Pfizer USD 5.02B 142M 2025-09
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12